Actively Recruiting
Study of Intra-Hepatic Microbiota in Adults with Alcoholic Hepatitis Using Liver Biopsy and Biological Samples
Led by Hospices Civils de Lyon · Updated on 2026-02-10
50
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
This research focuses on alcoholic hepatitis AH, a serious complication of alcoholic liver disease characterized by liver inflammation, fat buildup, and cell damage. Severe cases have a high risk of death within one month, and current treatment with corticosteroids only helps some patients. Researchers aim to better understand the role of gut bacteria in AH and how bacteria moving from the gut to the liver affect disease progression and outcomes. The study will include 50 patients suspected of having severe AH who will undergo a transjugular liver biopsy to collect liver tissue. Participants will be grouped based on biopsy results those with confirmed AH and those with alcoholic liver disease without AH. Researchers will analyze bacteria in liver tissue, blood, and stool samples using gene sequencing at the start, one month, and six months later to identify links between bacterial composition and clinical outcomes. Participants will provide liver biopsy samples and plasma and fecal samples at three timepoints baseline day 0, one month, and six months. Clinical data such as response to corticosteroids, survival, and liver function scores will be collected and correlated with microbiota findings. This study will help identify new targets for treatments focused on gut bacteria in alcoholic hepatitis. The study is conducted by Hospices Civils de Lyon and will run until mid-2028.
CONDITIONS
Brief Title
Intra-Hepatic Microbiota in Alcoholic Hepatitis
Research Team
F
François VILLERET, M.D., Ph.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here